DYNLT3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.065600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.468800E-01
Normal-vs-Stage2
3.166800E-01
Normal-vs-Stage3
6.168200E-01
Normal-vs-Stage4
2.677600E-01
Stage1-vs-Stage2
7.850400E-01
Stage1-vs-Stage3
8.778600E-01
Stage1-vs-Stage4
3.817200E-01
Stage2-vs-Stage3
6.981000E-01
Stage2-vs-Stage4
3.914800E-01
Stage3-vs-Stage4
4.979200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.217400E-01
Normal-vs-AfricanAmerican
3.118400E-01
Normal-vs-Asian
4.557000E-01
Caucasian-vs-AfricanAmerican
8.282200E-01
Caucasian-vs-Asian
3.935600E-01
AfricanAmerican-vs-Asian
6.168400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.337200E-01
Normal-vs-Female
2.895800E-01
Male-vs-Female
6.647200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.948800E-01
Normal-vs-Age(41-60Yrs)
1.260640E-01
Normal-vs-Age(61-80Yrs)
4.298600E-01
Normal-vs-Age(81-100Yrs)
7.205000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.214600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.461200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.048620E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.998900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.759180E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.104300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.788000E-01
Normal-vs-Daily Drinker
3.181600E-01
Normal-vs-Weekly Drinker
3.202000E-01
Normal-vs-Occasional Drinker
7.489700E-02
Normal-vs-Social Drinker
3.913000E-01
Non Drinker-vs-Daily Drinker
1.819160E-01
Non Drinker-vs-Weekly Drinker
7.728000E-01
Non Drinker-vs-Occasional Drinker
8.262300E-03
Non Drinker-vs-Social Drinker
3.972200E-01
Daily Drinker-vs-Weekly Drinker
2.863000E-01
Daily Drinker-vs-Occasional Drinker
4.239800E-01
Daily Drinker-vs-Social Drinker
6.801200E-01
Weekly Drinker-vs-Occasional Drinker
3.774300E-02
Weekly Drinker-vs-Social Drinker
6.070800E-01
Occasional Drinker-vs-Social Drinker
2.103800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.145600E-01
Normal-vs-Grade 2
1.129950E-01
Normal-vs-Grade 3
1.606600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.248800E-01
Grade 1-vs-Grade 3
7.783000E-01
Grade 1-vs-Grade 4
3.145600E-01
Grade 2-vs-Grade 3
7.667800E-01
Grade 2-vs-Grade 4
1.129950E-01
Grade 3-vs-Grade 4
1.606600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.926800E-01
Normal-vs-NonDiabetic
2.517000E-01
Diabetic-vs-NonDiabetic
1.444790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.264000E-01
Normal-vs-NoPancreatitis
2.912600E-01
Pancreatitis-vs-NoPancreatitis
4.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.516600E-01
Normal-vs-N1
3.037200E-01
N0-vs-N1
6.301400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.966400E-01
Normal-vs-TP53-NonMutant
7.486800E-01
TP53-Mutant-vs-TP53-NonMutant
5.836900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
